期刊文献+

乙型肝炎患者肝组织病理程度与血清乙型肝炎病毒DNA及乙型肝炎病毒e抗原的关系 被引量:4

Relationship between pathology in liver tissues and level of serum HBV-DNA,HBeAg of patients with chronic hepatitis B
在线阅读 下载PDF
导出
摘要 目的 观察慢性乙型肝炎肝纤维化及肝硬化患者肝组织病理严重程度与血清乙型肝炎病毒脱氧核糖核酸(HBV-DNA)、乙型肝炎病毒e抗原(HBeAg)的关系.方法 选择住院的慢性乙型肝炎、肝硬化患者55例,分别根据炎症及纤维化程度分为3组,行肝组织病理学检查,应用免疫荧光聚合酶链反应方法检测血清HBV-DNA的含量;应用酶联免疫吸附测定法检测血清HBeAg.结果 随炎症程度加重(G1~2,G3,G4),HBV-DNA(对数值)逐渐下降(6.19±1.36,5.42±1.52,4.42±1.33)(P〈0.05),HBV-DNA与炎症程度呈负相关(γs=-0.481,P〈0.01);随纤维化程度加重(S1-2,S3,S4),HBV-DNA亦逐渐下降(6.37±1.22,5.51±1.52,4.60±1.42),P〈0.05,与纤维化程度呈负相关(γs=-0.501,P〈0.01);同时HBeAg阳性率随炎症程度加重而下降(84.2%,57.1%,46.7%)(P〈0.05),亦随纤维化程度加重而下降(87.5%,61.1%,47.6%)(P〈0.05).结论 随肝组织病理程度加重,慢性肝炎患者血清HBV-DNA载量、HBeAg阳性率逐渐下降. Objective To study the relationship among pathology in liver tissues and level of hepatitis B virus DNA(HBV-DNA),hepatitis B e antigens(HBeAg) in serum of patients with chronic hepatitis B. Methods The liver biopsy was performed in 55 hospitalized patients. According to hepatitis grades(G) and fibrosis stages(S), the patients were divided into three groups. Hepatic pathology was examined, and the serum HBV-DNA level was tested by amolisensor quantitative polymerase chain reaction and serum HBeAg by enzyme linked immunosorbent assay. Results With the development of liver inflammation from G1-2 group to G3, G4 group,the serum HBV-DNA decreased (6.19 ± 1.36,5.42±1.52,4.42 ± 1.33) ( P 〈 0. 05 ), and HBV-DNA decreased from S1-2 group to S3, S4 group, too (6.37 ± 1.22,5.51± 1.52,4.60 ± 1.42)( P 〈0.05). The serum HBV-DNA was negative correlated with the hepatitis grades and fibrosis stages( γ = - 0. 481,0. 501, respectively, P 〈 0.01). The positive rate of serum HBeAg decreased from G1-2 group to G3, G4 group (84.2 %, 57.1 %, 46.7 % ) ( P 〈 0.05) ; and decreased from S1-2 group to S3 , S4 group, too (87.5 %,61.1% ,47.6 %)( P 〈 0.05). Conclusion With the development of liver fibrosis stages and grades in the patients with chronic hepatitis B,the serum level of HBV-DNA and the positive rate of HBeAg decreased.
出处 《临床荟萃》 CAS 北大核心 2006年第10期706-708,共3页 Clinical Focus
关键词 肝炎 乙型 肝硬化 肝炎e抗原 乙型 DNA复制 hepatitis B liver cirrhosis hepatitis B e antigens DNA replication
  • 相关文献

参考文献7

二级参考文献35

  • 1黄华芳,熊开钧,曾令兰,何生松,杨泽川,李援.高复制型慢性乙型肝炎血清HBV复制指标与肝脏病变关系的探讨[J].中国病毒学,1994,9(1):31-36. 被引量:5
  • 2病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 3田琦琦,贾克明.乙型肝炎病毒基因前C区变异的动态观察[J].中华内科杂志,1995,34(4):232-234. 被引量:28
  • 4王海涛 蒋豫图(等).北京某郊区乙型肝炎的流行病学研究[J].中华流行病学杂志,1985,16(2):110-110.
  • 5[2]骆抗先.乙型肝炎基础和临床,第二版.北京:人民卫生出版社,2001:117~120
  • 6[6]Sato S, Suzuki K, Akakane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant Hepatitis.Ann Intern Med, 1995,122:241 ~ 248
  • 7Leung N. Liver disease-significant improvement with lamivudine. J Med Vir, 2000, 61: 380-385.
  • 8Perrillo RP, Lai CL, Liaw YF, et al. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology, 2002,36: 186-194.
  • 9Kweon YO, Goodman ZD, Dienstag JL, et al. Decreasing fibrogenesis:an immunohistochemincal study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Heptol, 2001, 35:749-755.
  • 10卢桥生 骆抗先 等.HBV前C/C基因变异与重型肝炎的关系[J].中华肝脏病杂志,1997,5(1):31-31.

共引文献14058

同被引文献31

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部